Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

Treace Medical Concepts, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

PONTE VERDE, FLA., SEPT. 10, 2025 (GLOBE NEWSWIRE) -- TREACE MEDICAL CONCEPTS, INC. (TREACE OR THE COMPANY) (NASDAQGS: TMCI), A MEDICAL TECHNOLOGY COMPANY DRIVING A FUNDAMENTAL SHIFT IN THE SURGICAL TREATMENT OF BUNIONS AND RELATED MIDFOOT DEFORMITIES, TODAY ANNOUNCED IT WILL HIGHLIGHT NEW PRODUCT INNOVATIONS AND PRESENT NEW INTERIM DATA FOR THE ALIGN3D AND MTA3D CLINICAL STUDIES AT THE AMERICAN ORTHOPAEDIC FOOT & ANKLE SOCIETY (AOFAS) ANNUAL MEETING 2025 IN SAVANNAH, GEORGIA FROM SEPTEMBER 10-13, 2025.

TREACE HIGHLIGHTS NEW PRODUCT INNOVATIONS AND UPDATED POSITIVE CLINICAL STUDY DATA AT THE 2025 AMERICAN ORTHOPAEDIC FOOT & ANKLE SOCIETY ANNUAL MEETING

PONTE VEDRA, FLA., AUG. 07, 2025 (GLOBE NEWSWIRE) -- TREACE MEDICAL CONCEPTS, INC. ("TREACE" OR THE "COMPANY") (NASDAQGS: TMCI), A MEDICAL TECHNOLOGY COMPANY DRIVING A FUNDAMENTAL SHIFT IN THE SURGICAL TREATMENT OF BUNIONS AND RELATED MIDFOOT DEFORMITIES, TODAY REPORTED FINANCIAL RESULTS FOR THE SECOND QUARTER ENDED JUNE 30, 2025.

TREACE MEDICAL CONCEPTS REPORTSSECOND QUARTER 2025 FINANCIAL RESULTS

PONTE VEDRA, FLA., AUG. 07, 2025 (GLOBE NEWSWIRE) -- TREACE MEDICAL CONCEPTS, INC.(TREACE OR THE COMPANY) (NASDAQGS: TMCI), A MEDICAL TECHNOLOGY COMPANY DRIVING A FUNDAMENTAL SHIFT IN THE SURGICAL TREATMENT OF BUNIONS AND RELATED MIDFOOT DEFORMITIES, TODAY ANNOUNCED PLANS TO HOST AN INVESTOR DAY AT 9:00 AM E.T. ON SEPTEMBER 3, 2025, IN NEW YORK, NEW YORK. THE EVENT WILL INCLUDE PRESENTATIONS BY MEMBERS OF MANAGEMENT AND EXPERIENCED SURGEON USERS, HIGHLIGHTING THEIR EXPERIENCES WITH THE EXPANDED TECHNOLOGY PORTFOLIO.

TREACE MEDICAL TO HOST INVESTOR DAY HIGHLIGHTING NEW PRODUCTS ON SEPTEMBER 3, 2025

NEW YORK , JUNE 11, 2025 /PRNEWSWIRE/ -- KUEHN LAW, PLLC, A SHAREHOLDER LITIGATION LAW FIRM, IS INVESTIGATING WHETHER CERTAIN OFFICERS AND DIRECTORS OF TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) BREACHED THEIR FIDUCIARY DUTIES TO SHAREHOLDERS. ACCORDING TO A FEDERAL SECURITIES LAWSUIT, INSIDERS AT TREACE MEDICAL CAUSED THE COMPANY TO MISREPRESENT OR FAIL TO DISCLOSE (1) COMPETITION IMPACTED THE DEMAND FOR AND UTILIZATION OF ITS PRIMARY PRODUCT, THE LAPIPLASTY 3D BUNION CORRECTION SYSTEM; (2) AS A RESULT, TREACE MEDICAL'S REVENUE DECLINED, AND THE COMPANY NEEDED TO ACCELERATE ITS PLANS TO OFFER A PRODUCT THAT SERVED AS AN ALTERNATIVE TO OSTEOTOMY (A SURGICAL PROCEDURE INVOLVING THE CUTTING AND REALIGNMENT OF A BONE TO IMPROVE ITS POSITION OR FUNCTION); AND (3) POSITIVE STATEMENTS ABOUT THE COMPANY'S BUSINESS, OPERATIONS, AND PROSPECTS WERE MATERIALLY MISLEADING AND/OR LACKED A REASONABLE BASIS.

KUEHN LAW ENCOURAGES INVESTORS OF TREACE MEDICAL CONCEPTS, INC. TO CONTACT LAW FIRM

INVESTORS CAN CONTACT THE LAW FIRM AT NO COST TO LEARN MORE ABOUT RECOVERING THEIR LOSSES

TREACE MEDICAL CONCEPTS, INC. INVESTORS: PLEASE CONTACT THE PORTNOY LAW FIRM TO RECOVER YOUR LOSSES; JUNE 10, 2025 DEADLINE TO FILE LEAD PLAINTIFF MOTION

NEW YORK--(BUSINESS WIRE)---- $TMCI #CLASSACTION--FARUQI & FARUQI, LLP, A LEADING NATIONAL SECURITIES LAW FIRM, IS INVESTIGATING POTENTIAL CLAIMS AGAINST TREACE MEDICAL CONCEPTS, INC. (TREACE OR THE COMPANY) (NASDAQ: TMCI) AND REMINDS INVESTORS OF THE JUNE 10, 2025 DEADLINE TO SEEK THE ROLE OF LEAD PLAINTIFF IN A FEDERAL SECURITIES CLASS ACTION THAT HAS BEEN FILED AGAINST THE COMPANY. FARUQI & FARUQI IS A LEADING NATIONAL SECURITIES LAW FIRM WITH OFFICES IN NEW YORK, PENNSYLVANIA, CALIFORNIA AND GEORGIA.

FINAL DEADLINE ALERT: FARUQI & FARUQI, LLP INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF TREACE MEDICAL

NEW YORK, NY / ACCESS NEWSWIRE / JUNE 10, 2025 / IF YOU SUFFERED A LOSS ON YOUR TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) INVESTMENT AND WANT TO LEARN ABOUT A POTENTIAL RECOVERY UNDER THE FEDERAL SECURITIES LAWS, FOLLOW THE LINK BELOW FOR MORE INFORMATION: HTTPS://ZLK.COM/PSLRA-1/TREACE-MEDICAL-CONCEPTS-INC-LAWSUIT-SUBMISSION-FORM-2?PRID=152392&WIRE=1&UTM_CAMPAIGN=28 OR CONTACT JOSEPH E. LEVI, ESQ.

DID YOU LOSE MONEY ON TREACE MEDICAL CONCEPTS, INC. (TMCI)? LEVI & KORSINSKY URGES INVESTORS TO ACT BEFORE JUNE 10, 2025

NEW YORK, NY / ACCESS NEWSWIRE / JUNE 9, 2025 / IF YOU SUFFERED A LOSS ON YOUR TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) INVESTMENT AND WANT TO LEARN ABOUT A POTENTIAL RECOVERY UNDER THE FEDERAL SECURITIES LAWS, FOLLOW THE LINK BELOW FOR MORE INFORMATION: HTTPS://ZLK.COM/PSLRA-1/TREACE-MEDICAL-CONCEPTS-INC-LAWSUIT-SUBMISSION-FORM-2?PRID=152342&WIRE=1&UTM_CAMPAIGN=21 OR CONTACT JOSEPH E. LEVI, ESQ.

SHAREHOLDERS OF TREACE MEDICAL CONCEPTS, INC. (TMCI): PROTECT YOUR RIGHTS BEFORE JUNE 10, 2025 - CONTACT LEVI & KORSINSKY

NEW YORK, JUNE 09, 2025 (GLOBE NEWSWIRE) -- THE GROSS LAW FIRM ISSUES THE FOLLOWING NOTICE TO SHAREHOLDERS OF TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI).

TREACE MEDICAL CONCEPTS, INC. SUED FOR SECURITIES LAW VIOLATIONS  INVESTORS SHOULD CONTACT THE GROSS LAW FIRM FOR MORE INFORMATION  TMCI

NEW YORK, NY / ACCESS NEWSWIRE / JUNE 9, 2025 / IF YOU SUFFERED A LOSS ON YOUR TREACE MEDICAL CONCEPTS, INC. (NASDAQ:TMCI) INVESTMENT AND WANT TO LEARN ABOUT A POTENTIAL RECOVERY UNDER THE FEDERAL SECURITIES LAWS, FOLLOW THE LINK BELOW FOR MORE INFORMATION: HTTPS://ZLK.COM/PSLRA-1/TREACE-MEDICAL-CONCEPTS-INC-LAWSUIT-SUBMISSION-FORM-2?PRID=152258&WIRE=1&UTM_CAMPAIGN=18 OR CONTACT JOSEPH E. LEVI, ESQ.

Treace Medical Concepts, Inc.

TMCI

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Treace Medical Concepts, Inc.

TMCI.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

TMCI